This investigation looks into a contentious deal between a major pharmaceutical firm and the Guatemalan Social Security Institute (IGSS).
Following the deal, which prosecutors said the IGSS greenlit despite the firm’s lack of experience and infrastructure, dozens of patients with kidney disease died and scores of others were infected. The case would eventually reach the country’s highest courts where the elites implicated in the IGSS case had bought what some said was an insurance policy to make sure they would never be prosecuted.
Dead Kidney Patients
Ground to a halt in Guatemala City’s unrelenting morning traffic, a small team of government investigators began to worry they had lost their suspect. …
Stress Test for Guatemalan Justice
As day broke in Guatemala City on August 31, 2016, a judge named Carlos Ruano anxiously awaited a meeting with one of Guatemala’s most powerful magistrates.
And Impunity for All
On July 5, 2019, one of Guatemala’s deadliest and most infamous corruption cases landed in the murky world of the country’s appellate court. …
Related Content
Over the past several years, the United States has spent hundreds of millions of dollars on crime and violence prevention…
Latin American countries scored poorly on Transparency International’s latest corruption index, with the worst joining the ranks of war-torn nations…
A former Colombia governor accused of several murders and links to paramilitary groups came very close to being freed from…
Support Our Work
Investigating organized crime is an expensive and often risky enterprise. Reaching primary sources and getting the real story involve extensive fieldwork. Please donate. Every dollar supports our mission.
DONATE NOW